Javascript er ikke aktivert i din nettleser. Dette er nødvendig for å bruke Oncolex. Kontakt din systemadministrator for å aktivere JavaScript.

Endoscopic retrograde cholangiopancreatography (ERCP)


Plavix®, Clopidogrel®, Brillique®, Pradaxa®, Xarelto®, Eliquis®, Fragmin® or Marevan® (warfarin) should be stopped  to reduce the risk of bleeding during the procedure, if the patients general practitioner doesn´t decides otherwise.

  • Plavix®, Clopidogrel® and Brilique® may be taken up to seven days before the procedure.
  • Pradaxa®, Xarelto® and Eliquis® may be taken up to 48 hours before the procedure.
  • Marevan® (warfarin) may be taken up to 48 hours before the procedure, and the patient must also have an INR control at least an hour before the examination.
  • The patient may continue to take Albyl-E® (acetylsalicylic acid).
  • Fragmin® injections may be taken until the night before the procedure.
  • If the patient has an artificial heart valve, contact the ward in charge of the excamination.

The stomach must be empty before the procedure.

  • The patient can´t eat or drink anything in the last six hours before the procedure.
  • If the patient is very thirsty he/she may drink 1-2 glasses of water until two hours before the procedure, and then only rinse the mouth without swallowing anything.

If the patient have diabetes and use insulin or other essential medecines that can´t be postponed, the patient can get an appointment early in the day.

The procedure is usually carried out under light sedation with Dormicum®/Pethidin®, however propofol-anesthesia is becoming more common. General anesthesia is only exceptionally use.

Oslo University Hospital shall not be liable for any loss whether direct, indirect, incidental or consequential, arising out of access to, use of, or reliance upon any of the content on this website. Oslo University Hospital© 2018